Arthur F. Golden, Director at Turn Therapeutics Inc. (TTRX), bought 41,064 shares at $2.87 ($118K) on 2025-11-21, disclosed to the SEC on 2025-11-24.
Open-market purchase of $118k TTRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.87 | 20,532 | $59K | 50.0% |
| 2 | $2.87 | 20,532 | $59K | 50.0% |
| Total | $2.87 avg | 41,064 | $118K | 100% |
| Filing → |
| EMR | BUY | 2023-11-13 | $257K | — | Filing → |
| EMR | BUY | 2020-03-11 | $257K | — | Filing → |
| EMR | BUY | 2015-08-10 | $198K | — | Filing → |